Diabetes, Digestive, Kidney Extramural Research – Special Diabetes Program

CFDA 93.KT1 Active Grant

Program Funding

Annual program obligations reported to SAM.gov.

Latest annual funding (estimated)
$159M FY2026
$127M
FY24
$180.5M
FY25
$159M
FY26*
* estimated

Funded Projects

Examples of what this program has supported.

FY2025 FY 2025 Actual:
Research Project Grants: $158,761,000 with 147 awards; SBIR/STTR: $5,610,000 with 9 awards; Other Research: $16,098,000 with 7 awards.
FY2026 FY 2026 Current Year Estimate:
Research Project Grants: $134,696,000 with 179 awards estimated; SBIR/STTR: $5,804,000 with 14 awards estimated; Other Research: $18,500,000 with 10 awards estimated.

Program Objective

To promote extramural basic and clinical biomedical research that improves the understanding of the mechanisms underlying Type 1 Diabetes and leads to improved preventions, diagnosis, treatment, and cure of Type 1 Diabetes. NIDDK administers the Special Statutory Funding Prgoram for Type 1 Diabetes Research or Special Diabetes Program on behalf of the Secretary of the Department of Health and Human Services, in collaboration with multiple NIH Institutes and Centers and the CDC, and with input from the Diabetes Mellitus Interagency Coordinating Committee. Specific programs areas of interest include fundamental and clinical studies including the etiology, pathogenesis, prevention, diagnosis, treatment and cure of Type 1 Diabetes and its complications.

Eligibility

Eligible Applicants

  • U.S. State Government
  • Nonprofit Organization
  • Not-for-Profit Organization
  • Federally Recognized Tribal Government
  • Small Business Person

Eligible Organizations: For non-SBIR/STTR awards, universities, colleges, medical, dental and nursing schools, schools of public health, laboratories, hospitals, State and local health departments, other public or private institutions, both non-profit and for-profit, and individuals who propose to establish, expand, and improve research activities in health sciences and related fields. Eligible Individuals (Program Director/Principal Investigator (PD/PI)): Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the PD(s)/PI(s) is invited to work with his/her organization to develop an application for support. SBIR and STTR grants can be awarded only to domestic small businesses that meet the following criteria: 1) Is independently owned and operated, is not dominant in the field of operation in which it is proposing, has a place of business in the United States (US) and operates primarily within the US or makes a significant contribution to the US economy, and is organized for profit; 2) Is (a) at least 51% owned and controlled by one or more individuals who are citizens of, or permanent resident aliens in, the US, or (b) for SBIR only, it must be a for-profit business concern that is at least 51% owned and controlled by another for-profit business concern that is at least 51% owned and controlled by one or more individuals who are citizens of, or permanent resident aliens in, the US. 3) Has, including its affiliates, an average number of employees for the preceding 12 months not exceeding 500, and meets the other regulatory requirements found in 13 C.F.R. Part 121. Business concerns are generally considered to be affiliates of one another when either directly or indirectly, (a) one concern controls or has the power to control the other; or (b) a third-party/parties controls or has the power to control both. STTR grants which "partner" with a research institution in cooperative research and development. At least 40% of the project is to be performed by the small business concern and at least 30% by the research institution.

Beneficiaries

  • Nonprofit Organization
  • Not-for-Profit Organization
  • Trainee
  • Graduate and Professional Higher Education
  • Scientist / Researcher
  • Small Business Person
  • U.S. Citizen

Health professionals, graduate students, health professional students, scientists, and researchers, any nonprofit or for-profit organization, company, or institution engaged in biomedical research. US-owned and operated small businesses and associated health professionals, scientists, and researchers, engaged in biomedical research. Program Director(s)/Principal Investigator(s): Although no degree of education is either specified or required, nearly all successful applicants have doctoral degrees in one of the sciences or professions.

How to Apply

Award Procedure

Grant applications are reviewed initially for scientific merit by an appropriate peer review panel and by the National Diabetes and Digestive and Kidney Diseases Advisory Council composed of leaders in medical science, education, and public affairs. Approved applications will compete on a merit basis for available funds. Successful applicants are sent a Notice of Grant Award.
All accepted SBIR/STTR applications are evaluated for scientific and technical merit by an appropriate scientific peer review panel and by a national advisory council or board. All applications receiving a priority score compete for available SBIR/STTR set-aside funds on the basis of scientific and technical merit and commercial potential of the proposed research, program relevance, and program balance among the areas of research. The successful applicant is sent a Notice of Grant Award.

Project Grants: From 6 to 9 months.
SBIR/STTR applications: About 7-1/2 months.

Program details & compliance

Description

To promote extramural basic and clinical biomedical research that improves the understanding of the mechanisms underlying Type 1 Diabetes and leads to improved preventions, diagnosis, treatment, and cure of Type 1 Diabetes. NIDDK administers the Special Statutory Funding Prgoram for Type 1 Diabetes Research or Special Diabetes Program on behalf of the Secretary of the Department of Health and Human Services, in collaboration with multiple NIH Institutes and Centers and the CDC, and with input from the Diabetes Mellitus Interagency Coordinating Committee. Specific programs areas of interest include fundamental and clinical studies including the etiology, pathogenesis, prevention, diagnosis, treatment and cure of Type 1 Diabetes and its complications.

Mission Categories

Primary: Prevention and Control (includes Suicide Prevention)

Use of Funds

Allowed Uses

Health/Medical, Higher Education (includes Research): Project Grants provide funds for salaries, equipment, supplies, travel, and other expenses associated with scientific investigation relevant to program objectives. SBIR Phase I grants (of approximately 6-months duration) are to establish the technical merit and feasibility of a proposed research effort that may lead to a commercial product or process. Phase II grants are for the continuation of the research initiated in Phase I and that are likely to result in commercial products or processes. Only Phase I awardees are eligible to receive Phase II support. STTR Phase I grants (normally of 1-year duration) are to determine the scientific, technical, and commercial merit and feasibility of the proposed cooperative effort that has potential for commercial application. Phase II funding is based on results of research initiated in Phase I and scientific and technical merit and commercial potential of the Phase II application.

Restrictions

Specific Restrictions Determined at NOFO Level

Required Documentation

Each applicant for research projects must present a research plan and furnish evidence that scientific competence, facilities, equipment, and supplies are appropriate to carry out the plan. For-profit organizations' costs are determined in accordance with Subpart 31.2 of the Federal Acquisition Regulations. For SBIR and STTR grants, applicant organization (small business concern) must present in a research plan an idea that has potential for commercialization and furnish evidence that scientific competence, experimental methods, facilities, equipment, and funds requested are appropriate to carry out the plan. Grant form PHS 398 is used to apply for SBIR and STTR Phase I Phase II and Phase I/Phase II Fast Track. For other grantees, costs will be determined in accordance with HHS Regulations 45 CFR, Part 75, Subpart Q.

Reporting & Compliance

Audit Required
Yes — Ad-hoc
Records Retention
3 years

Applicable 2 CFR 200 Subparts

  • Subpart B — General Provisions
  • Subpart C — Pre-Federal Award Requirements
  • Subpart D — Post-Federal Award Requirements
  • Subpart E — Cost Principles
  • Subpart F — Audit Requirements

Contacts

NIDDK GMB Branch
301.402.8108
6707 Democracy Blvd., Bethesda, MD 20892
Data from SAM.gov Federal Assistance Listings. Source published: 2026-01-30. Spec v2.0. Last synced: 2026-05-29 05:39:31.